Article
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
16 Mar 2022
Abstract excerpt
Immune response has been shown to play an important role in defining patient prognosis and response to cancer treatment. Tumor-induced immunosuppression encouraged the recent development of new chemotherapeutic agents that assists in the augmentation of immune responses. Molecular mechanisms that tumors use to evade immunosurveillance are attributed to their ability to alter antigen processing/presentation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
